, Baudouin, C
This article does not constitute medical advice and is not a substitute for consultation with a qualified healthcare professional
Semaglutide microdosing usually ranges from $150$300, while tirzepatide microdosing typically runs $250$450
In 2023, Pfizer published research papers successively, reporting the results of randomized clinical trials on the efficacy and safety of PF-06882961 for blood sugar control in patients with type 2 diabetes, the safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06882961 in Japanese adults with type 2 diabetes from a phase 1 clinical trial, and the results of a 12-week randomized, placebo-controlled, dose-escalation phase 2 trial on the tolerability, safety, and pharmacodynamics of PF-06882961 for the treatment of type 2 diabetes
Research is investigating its effects on non-alcoholic steatohepatitis (NASH), cardiovascular outcomes, and its role in reducing the risk of developing type 2 diabetes in individuals with prediabetes